Physician profile
Angel E Michel
NPI 1235281346
$2,038.42
in general payments reported to CMS, 2019-2025
12 companies · $74.64 in 2025
The $74.64 reported for 2025 was less than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,012 · 2020: $42.95 · 2021: $393 · 2022: $166 · 2023: $235 · 2024: $115 · 2025: $74.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $424.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $499.27 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $361.50 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $319.89 | 2019-2024 | Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $204.36 | 2020-2021 | |
| Pfizer Pharmaceuticals LLC | $136.65 | 2019 | |
| Boston Scientific Corporation | $126.80 | 2023 | Watchman Access System |
| Glaxosmithkline, LLC. | $104.48 | 2019-2025 | |
| Lilly USA, LLC | $90.85 | 2019 | |
| Sanofi-Aventis U.S. LLC | $73.63 | 2019 | |
| Amgen INC. | $63.34 | 2023 | Prolia |
| Pbg Puerto Rico LLC | $34.31 | 2019-2021 | |
| Pfizer INC. | $23.34 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angel Michel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.